Article Versions Notes

Xu P, Qu H, Yang JC, Wei F, Zhao J, Tang M, Wang L, Nip C, Li H, Gao AC, et al. Dynamic Reprogramming of Immune-Related Signaling During Progression to Enzalutamide Resistance in Prostate Cancer. Cancers. 2025; 17(19):3187. https://doi.org/10.3390/cancers17193187

Xu, Pengfei, Huan Qu, Joy C. Yang, Fan Wei, Junwei Zhao, Menghuan Tang, Leyi Wang, Christopher Nip, Henson Li, Allen C. Gao, and et al. 2025. "Dynamic Reprogramming of Immune-Related Signaling During Progression to Enzalutamide Resistance in Prostate Cancer" Cancers 17, no. 19: 3187. https://doi.org/10.3390/cancers17193187

Xu, P., Qu, H., Yang, J. C., Wei, F., Zhao, J., Tang, M., Wang, L., Nip, C., Li, H., Gao, A. C., Lam, K., Dall'Era, M., Li, Y., & Liu, C. (2025). Dynamic Reprogramming of Immune-Related Signaling During Progression to Enzalutamide Resistance in Prostate Cancer. Cancers, 17(19), 3187. https://doi.org/10.3390/cancers17193187